Protein Characterization

Among small molecule drugs, such as small RNAs, oligonucleotides, peptides or vaccines, recombinant proteins are the most commonly. The discovery and development of protein therapeutics is growing rapidly because of their cell-specific modality and relative lack of compound-specific toxicity, and soon will equal and even surpass chemical entity drug development.

By stringently monitoring both the manufacturing process over time and the finished product, drug manufacturers must ensure product consistency, quality, and purity. Therefore, to support and guide decisions made in developing the manufacturing process and product formulation of protein therapeutics, accurate and reproducible characterization methods are therefore an absolute requirement. A biologic must be "well-characterized" to assure its safety and efficacy. For protein pharmaceuticals, well-characterized means that the identity, heterogeneity, impurity, and potency can be defined with a high degree of confidence. Considering the complexity of the proteins, there is no one analytical platform or application that can meet all of these needs.

Proein-Characterization-Fig1Fig1. ICH Guidelines for Protein Drug Characterization

Protein characterization pose significant challenges. Most of the time, protein drugs are heterogeneous mixtures of closely related molecular weights and charged isoforms derived from living cells and usually include a complex pattern of product- and process-related impurities. What's more, recombinant proteins are complex: various post-translational modifications, a highly specific three-dimensional structure, and the potential for aggregation, adsorption, and truncation. The precise amino acid sequence, molecular weight, charge variances, glycosylation, aggregation level and oxidation level are all important components of thorough characterization of a protein drug.

In line with the ICH Q6B Guidance, Creative Proteomics offers protein analysis and characterization services including structure analysis, physicochemical properties, biological activity, immunochemical properties and purity and impurities determination to ensure the quality and consistency of your product. Creative Proteomics can fully characterize any protein biopharmaceuticals for the Chemistry and Manufacturing Controls (CMC) section of Investigational New Drug applications (INDs), New Drug Applications (NDAs) and Biologic License Applications (BLAs). Protein drug characterization services available at Creative Proteomics are as below.

Protein Characterization
Protein Identification

Molecular Weight


Protein Sequence

N-terminal Sequencing
C-terminal Sequencing and Blocked N-terminal
Sequencing with MALDI-ISD
Peptide Mapping
Peptide Mass Fingerprinting
De novo Sequencing
Amino Acids Composition Analysis
Extinction Coefficient
Differential Scanning Calorimetric (DSC)

Isoelectric Point

Flat Gel Isoelectric Focusing
Capillary Isoelectric Focusing
Protein Aggregation Analysis Protein Purity Analysis (SDS-PAGE)
Protein Purity Analysis Protein Purity Analysis (HPLC)
Protein Polymer Analysis (HPLC)
Protein Fragment Analysis (HPLC)
Protein Isoform Analysis (Capillary Isoelectric Focusing)
Host Cell Proteins Analysis
Host Cell Residual DNA analysis
Glycosylation Analysis N-glycans Profiling
O-Glycans Profiling
N-glycan Sites Occupation Analysis
O-Glycans Sites Occupation Analysis
Glycopeptides Analysis
Siliac Acid Analysis
Phosphorylation Analysis
Deamidationand Oxidation Analysis
Disulfide Bridges & Free Sulfhydryl Groups
N-acetylation Analysis
Methylation Analysis
Ubiquitination Analysis
Sumoylation Analysis
Lipidation Analysis
S-nitrosylation Analysis
N-myristoylation Analysis
S-palmitoylation Analysis
S-prenylation Analysis
Secondary Structure Analysis Circular Dichroism Spectra (Far UV)
Fluorescence Spectroscopy
Nuclear Magnetic Resonance (NMR) spectroscopy
 FT-infrared Spectroscopy
Tertiary Structure Analysis Circular Dichroism Spectra (Near UV)
Hydrogen Deuterium Exchange Mass
Spectrometry (HDX-MS)
X-ray Crystallography

For more details, please feel free to contact us or send inquiry directly.

*For Research Use Only. Not for use in the treatment or diagnosis of disease.

Online Inquiry

Great Minds Choose Creative Proteomics